RecruitingPhase 2NCT07407491

Comparative Efficacy Of Intraductal Antibiotic During ERCP In Acute Cholangitis

Comparative Efficacy Of Intraductal Antibiotic During ERCP In Acute Cholangitis: A Randomized Controlled Trial

Sponsor

National University of Malaysia

Enrollment

172 participants

Start Date

Jul 9, 2024

Study Type

INTERVENTIONAL

Conditions

Biliary tract infection Choledocholithiasis Malignant Biliary Stricture Acute Cholangitis Biliary Obstruction

Summary

Does intraductal administration of antibiotics during endoscopic retrograde cholangiopancreatography (ERCP), in addition to standard systemic antibiotic therapy, improve clinical outcomes in patients with acute cholangitis compared with standard systemic antibiotic therapy alone?

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Distilled water and a drug called Gentamicin - single dose for people with acute cholangitis, biliary obstruction, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.